CompletedPhase 1NCT02736565
Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Studying Extraskeletal Ewing sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gradalis, Inc.
- Principal Investigator
- John Nemunaitis, MDGradalis, Inc.
- Intervention
- pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex(biological)
- Enrollment
- 7 enrolled
- Eligibility
- 8 years · All sexes
- Timeline
- 2016 – 2020
Study locations (2)
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Mary Crowley Cancer Research Centers, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02736565 on ClinicalTrials.gov